Author:
Hsueh Eddy C.,Famatiga Estela,Shu Sherry,Ye Xing,Morton Donald L.
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Atkins MB, Lotze MT, Dutcher JP, et al. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J Clin Oncol 1999; 17: 2105–16.
2. Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996; 14: 7–17.
3. Ferrone S. Human tumor-associated antigen mimicry by anti-idiotypic antibodies: immunogenicity and clinical trials in patients with solid tumors. Ann NY Acad Sci 1993; 690: 214–24.
4. Ayyoub M, Zippelius A, Pittet MJ, et al. Activation of human melanoma reactive CD8+ T-cells by vaccination with an immunogenic peptide analog derived from Melan-A/Melanoma Antigen Recognized by T Cells-1. Clin Cancer Res 2003; 9: 669–77.
5. Machiels JP, van Baren N, Marchand M. Peptide-based cancer vaccines. Semin Oncol 2002; 29: 494–502.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献